Abstract
Procalcitonin was introduced to management of hospital-acquired pneumonia/ventilatorassociated pneumonia (HAP/VAP) by the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA), in its 2005 HAP guidelines. It was based on the assumption that positive procalcitonin (PCT) results indicative of HAP/VAP of bacterial aetiology will prompt antibiotic therapy, and improve clinical outcomes. Antibiotic stewardship by monitoring of PCT kinetics resulted in shorter antibiotic treatment durations with early cessation of therapies. The diagnostic part is no more recommended due to weak evidence from studies. Beyond diagnostic uses, some studies have shown that positive PCT levels are associated with poorer clinical outcomes in HAP/VAP, Healthcare-associated pneumonia and community-acquired pneumonia. The article will discuss the diagnostic role briefly and mainly the role as a prognostic indicator in the management of HAP/VAP.
Keywords: Hospital acquired, mortality, pneumonia, procalcitonin, respiratory tract infection, ventilator associated pneumonia.
Current Respiratory Medicine Reviews
Title:Utility of Procalcitonin in the Management of Hospital-Acquired Pneumonia - A Review
Volume: 14 Issue: 1
Author(s): Sandeep Kumar*, Rafi Ahmed Jan, Roohi Rasool, Bashir Ahmad Fomda and Parvaiz A. Koul
Affiliation:
- Department of Internal Medicine, Sher I. Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir 190010,India
Keywords: Hospital acquired, mortality, pneumonia, procalcitonin, respiratory tract infection, ventilator associated pneumonia.
Abstract: Procalcitonin was introduced to management of hospital-acquired pneumonia/ventilatorassociated pneumonia (HAP/VAP) by the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA), in its 2005 HAP guidelines. It was based on the assumption that positive procalcitonin (PCT) results indicative of HAP/VAP of bacterial aetiology will prompt antibiotic therapy, and improve clinical outcomes. Antibiotic stewardship by monitoring of PCT kinetics resulted in shorter antibiotic treatment durations with early cessation of therapies. The diagnostic part is no more recommended due to weak evidence from studies. Beyond diagnostic uses, some studies have shown that positive PCT levels are associated with poorer clinical outcomes in HAP/VAP, Healthcare-associated pneumonia and community-acquired pneumonia. The article will discuss the diagnostic role briefly and mainly the role as a prognostic indicator in the management of HAP/VAP.
Export Options
About this article
Cite this article as:
Kumar Sandeep*, Jan Ahmed Rafi , Rasool Roohi, Fomda Ahmad Bashir and Koul A. Parvaiz, Utility of Procalcitonin in the Management of Hospital-Acquired Pneumonia - A Review, Current Respiratory Medicine Reviews 2018; 14 (1) . https://dx.doi.org/10.2174/1573398X14666180601073756
DOI https://dx.doi.org/10.2174/1573398X14666180601073756 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nociceptin / Orphanin FQ (NOP) Receptors as Novel Potential Target in the Treatment of Gastrointestinal Diseases
Current Drug Targets Vasculitis Following Influenza Vaccination: A Review of the Literature
Current Rheumatology Reviews The Oxygen Therapy
Current Medicinal Chemistry Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Non-Peptidic Inhibitors of Cysteine Proteases
Mini-Reviews in Medicinal Chemistry Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters HSV Amplicon Vectors for Cancer Therapy
Current Gene Therapy Synthesis and In Vitro Antibacterial Screening of some New 2,4,6-Trisubstituted-1,3,5-Triazine Derivatives
Letters in Drug Design & Discovery Small Molecule Antagonists of Integrin Receptors
Current Medicinal Chemistry Emerging Breast Cancer Biomarkers
Current Cancer Therapy Reviews Effects of Statins on Transplant Graft Arterial Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Nanocrystal Technology in the Delivery of Poorly Soluble Drugs: An Overview
Current Drug Delivery Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines
Current Stem Cell Research & Therapy Reverse Pharmacognosy: Application of Selnergy, a New Tool for Lead Discovery. The Example of ε-Viniferin
Current Drug Discovery Technologies Propofol Rescued Astrocytes from LPS-induced Inflammatory Response via Blocking LncRNA-MEG3/NF-κB Axis
Current Neurovascular Research Curcumin Loaded Ethosomal Gel for Improved Topical Delivery: Formulation, Characterization and <i>Ex-vivo</i> Studies
Pharmaceutical Nanotechnology Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Transgenic Mouse Models for Immunosenescence
Current Genomics